http://www.free-press-release.com/news-new-website-aims-to-clear-up-misconceptions-about-breakthrough-drug-low-dose-naltrexone-ldn-1268301980.html
“Having instigated the first clinical trial for LDN in 2004 at Penn
State University, I am gratified that we’ve now launched this
informative resource for physicians and patients,” Rogosnitzky added.
“We aim to summarize almost 30 years of research, carried out by the
discoverers of LDN, Dr. Ian S. Zagon and Dr. Patricia J. McLaughlin at
Penn State University, and provide an invaluable resource which will
enable this therapy to be used properly, inspire further research into
its many possible uses and eventually lead to its acceptance as
mainstream therapy for a number of incurable conditions.”
--
The Silver List is a moderated forum for discussing Colloidal Silver.
Rules and Instructions: http://www.silverlist.org
Unsubscribe:
<mailto:[email protected]?subject=unsubscribe>
Archives:
http://www.mail-archive.com/[email protected]/maillist.html
Off-Topic discussions: <mailto:[email protected]>
List Owner: Mike Devour <mailto:[email protected]>
